25 ago
|
Institut D'Investigació Biomédica De Bellvitge (Idibell)
|
España
25 ago
Institut D'Investigació Biomédica De Bellvitge (Idibell)
España
Organisation/Company Institut d'Investigacio Biomedica de Bellvitge (IDIBELL) Department RRHH Research Field Biological sciences Other Researcher Profile Other Profession Positions Bachelor Positions Application Deadline 7 Oct 2026 - 23:59 (Europe/Madrid) Country Spain Type of Contract Permanent Job Status Full-time Hours Per Week 40 Offer Starting Date 21 Sep 2026 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Reference Number 26-126_SS_VN Is the Job related to staff position within a Research Infrastructure? No
Offer Description
Our institute
IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.
IDIBELL is located in L’Hospitalet de Llobregat, south of Barcelona. It is a member of the Campus of International Excellence of the University of Barcelona (HUBc) and Research Centers of Catalonia (CERCA). In 2009, it became one of the first five Spanish research centers accredited as a health research institute by the Health Institute Carlos III. In 2015, the European Commission recognized IDIBELL with the 'HR Excellence in Research' award, which identifies IDIBELL as a provider and supporter of a stimulating research work environment.
About the research group/unit
ICO-L’Hospitalet is a reference hospital for the clinical research in cancer. Their two units (UIC and UFF1) have been participating in 602 clinical trials with active recruitment or with current activities during 2025 and 695 patients decided to participate in them. Many of these trials are testing the most promising therapies
📌 26-126_SS_VN Study Coordinator for Cancer Clinical Trials (España)
🏢 Institut D'Investigació Biomédica De Bellvitge (Idibell)
📍 España